Fulcrum Therapeutics Inc.
FULC | NASDAQ
$3.81
+$0.02 (+0.40%)
Sep 22, 2026, 10:37 AM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -26.18M | -18.89M | -20.33M | -19.6M | -17.3M | -17.66M | -16.57M | -21.7M | 55.41M | -26.87M | -24.76M | -24.02M | -23.78M | -24.78M | -26.14M | -23.74M | -34.07M | -25.93M | -23.48M | -20.72M | -19.65M | -17M |
Depreciation & Amortization | 216K | 338K | 347K | 346K | 344K | 353K | 369K | 400K | 400K | 479K | 508K | 531K | 567K | 566K | 591K | 611K | 676K | 536K | 621K | 619K | 672K | 603K |
Stock-Based Compensation | 3.27M | 3.86M | 3.07M | 3.36M | 2.88M | 3.17M | 2.48M | 3.82M | 4.34M | 3.92M | 3.45M | 3.74M | 3.36M | 4.25M | 3.27M | 3.35M | 2.88M | 3.85M | 3.79M | 2.66M | 2.55M | 2.07M |
Other Working Capital | 4.15M | -4.15M | 1.61M | 1.34M | 119K | -1.68M | -957K | 616K | 2.53M | -3.29M | -257K | -1.36M | 1.17M | -3.01M | 1.7M | -6.01M | 3.2M | -4.26M | -1.88M | -3.89M | -1.09M | -4.9M |
Other Non-Cash Items | 3.36M | -767K | -383K | -586K | -1.09M | -899K | -945K | 2.63M | 3.19M | -1.16M | -1.33M | -1.59M | -1.71M | -1.37M | -601K | 112K | 288K | 353K | 386K | 92K | 121K | 74K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 3.29M | -3.29M | 506K | 2.29M | 1.34M | -223K | -2.09M | -410K | -96K | -1.65M | -1.03M | -1.57M | 780K | -2.79M | 3.18M | -8.22M | 2.86M | -914K | -3.17M | -5.23M | -1.51M | -1.98M |
Operating Cash Flow | -16.04M | -18.75M | -16.8M | -14.19M | -13.82M | -15.26M | -16.76M | -19.07M | 58.9M | -25.28M | -23.16M | -22.91M | -20.79M | -24.12M | -19.7M | -27.88M | -27.37M | -22.11M | -21.86M | -22.57M | -17.82M | -16.23M |
Capital Expenditures | -108K | -8K | -159K | -90K | -65K | n/a | -231K | -19K | n/a | -28K | -77K | -65K | -195K | -171K | -116K | -283K | -1.32M | -246K | -519K | -367K | -565K | -262K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 93.77M | n/a | 2M | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -24.22M | -155.34M | -26.14M | -17.29M | -76.39M | -60.4M | -21.41M | -38.13M | -63.24M | -55.82M | -25.07M | -25.99M | -17.33M | -126.5M | -83.29M | -52.7M | -10.18M | -4.99M | -34.89M | -129.56M | -48.79M | -3M |
Sales Maturities Of Investments | 37.65M | 27.14M | 25.25M | 36M | 90.39M | 59.62M | 23.9M | 42.5M | 50.73M | 93.97M | 43.51M | 45.07M | 37.4M | 32.73M | 47.04M | 50.7M | 42.89M | 24.9M | 26.31M | 23.3M | 23M | 15.67M |
Other Investing Acitivies | 450K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -93.77M | n/a | -2M | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | 13.78M | -128.21M | -1.05M | 18.61M | 13.93M | -777K | 2.26M | 4.35M | -12.51M | 38.13M | 18.35M | 19.02M | 19.88M | -93.94M | -36.36M | -2.28M | 31.4M | 19.66M | -9.09M | -106.64M | -26.35M | 12.42M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1K | 1K | -5K | -13K |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 356K | -333K | n/a | n/a | n/a | n/a | 83K | n/a | n/a | n/a | n/a | n/a | 142K | 348K | 267K | 93K | 2.81M | 348K | 969K | 2.38M | 231K | 93K |
Financial Cash Flow | 356K | -312K | 168.3M | 64K | 301K | n/a | 83K | 635K | 377K | 1.65M | 287K | n/a | 142K | 117.69M | 218K | 80.95M | 2.81M | 348K | 891K | 137.9M | 209K | 47.5M |
Net Cash Flow | -1.9M | -147.27M | 150.46M | 4.49M | 414K | -16.03M | -14.42M | -14.07M | 46.75M | 14.39M | -4.52M | -3.89M | -768K | -364K | -55.84M | 50.79M | 6.84M | -2.1M | -30.06M | 8.69M | -43.97M | 43.69M |
Free Cash Flow | -16.15M | -18.76M | -16.96M | -14.28M | -13.89M | -15.26M | -16.99M | -19.09M | 58.9M | -25.31M | -23.24M | -22.97M | -20.98M | -24.29M | -19.81M | -28.17M | -28.68M | -22.35M | -22.38M | -22.94M | -18.39M | -16.49M |
Adj. Free Cash Flow | -19.42M | -22.62M | -20.02M | -17.64M | -16.76M | -18.42M | -19.47M | -22.91M | 54.56M | -29.23M | -26.68M | -26.71M | -24.34M | -28.54M | -23.08M | -31.52M | -31.56M | -26.2M | -26.17M | -25.6M | -20.93M | -18.56M |
Maintenance CapEx | -108K | -8K | -159K | -90K | -65K | n/a | -231K | -19K | n/a | -28K | n/a | -65K | -195K | -171K | -116K | -283K | -1.32M | -246K | n/a | n/a | n/a | n/a |
Growth CapEx | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -77K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -519K | -367K | -565K | -262K |
Owner Earnings | -16.15M | -18.76M | -16.96M | -14.28M | -13.89M | -15.26M | -16.99M | -19.09M | 58.9M | -25.31M | -23.16M | -22.97M | -20.98M | -24.29M | -19.81M | -28.17M | -28.68M | -22.35M | -21.86M | -22.57M | -17.82M | -16.23M |
Add to Watchlist
Select watchlists to add or remove FULC